NanoVision Diagnostics

NanoVision Diagnostics is commercializing a novel electro-optical cancer diagnostic system 1000 times more sensitive than an optical microscope. This system is able to detect molecular changes in a standard biopsy slide. The company will offer its proprietary technology as a diagnostic service.

Funding: Private Angels, North Coast Angels

Stage: Clinical

News: NanoVision Diagnostics Raises $1.5 Million